Taglich Brothers Initiates Coverage of Global WholeHealth Partners Corp.
October 16, 2020 09:30 ET
|
Taglich Brothers Inc
NEW YORK, Oct. 16, 2020 (GLOBE NEWSWIRE) -- Taglich Brothers, Inc. announces that it has initiated coverage of Global WholeHealth Partners Corp. (OTC: GWHP). Global WholeHealth Partners Corp.,...
Co-Diagnostics, Inc. Adds to Menu of Molecular Vector Control Products
October 10, 2019 06:30 ET
|
Co-Diagnostics
Salt Lake City, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic...
GeoVax Announces Reverse Stock Split
May 03, 2019 08:59 ET
|
GeoVax, Inc.
1:500 Reverse Split Effective May 2, 2019;Ticker Symbol Changed to GOVXD for 20 Days ATLANTA, GA, May 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX) today...
GeoVax Provides Product Development and Corporate Update
March 11, 2019 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, March 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines and immunotherapies using its novel viral vector...
PacBio’s SMRT Sequencing Provides Unprecedented Insight into Genome of Disease-causing Mosquito
November 14, 2018 13:00 ET
|
Pacific Biosciences of California, Inc.
Improved Reference Genome for Aedes aegypti, Carrier of Zika Virus and Other Public Health Threats, Published in Nature MENLO PARK, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences...
GeoVax Presenting at Upcoming Scientific Conferences
November 07, 2018 09:00 ET
|
GeoVax, Inc.
Plug & Play Platform Continues to be Recognized for Distinct Benefits ATLANTA, GA, Nov. 07, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology...
Aphios Is Developing Pathogen Inactivation Technology For Human Plasma Units
September 26, 2018 08:00 ET
|
Aphios
WOBURN, Mass., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Aphios Corporation today announced that it has been awarded a Phase I Small Business Innovative Research (SBIR) grant from the National Heart Lung...
GeoVax Strengthens Scientific Staff and Expertise
August 29, 2018 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, Aug. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today announced the strengthening of its...
QualTex Laboratories Implements New Zika Testing Guidance from U.S. Food and Drug Administration
August 22, 2018 09:00 ET
|
BioBridge Global
San Antonio, Aug. 22, 2018 (GLOBE NEWSWIRE) -- QualTex Laboratories is up and running with new guidance for testing blood donations for the Zika virus, just weeks after the Food and Drug...
GeoVax to Present at the American Society for Virology 2018 Annual Meeting
July 09, 2018 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, July 09, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), winner of the 2018 “Best Biotech” at the Vaccine Industry Excellence (ViE) Awards during the World Vaccine Congress,...